Kristin C. Peck
Net Worth
Last updated:
What is Kristin C. Peck net worth?
The estimated net worth of Ms. Kristin C. Peck is at least $85,135,613 as of 20 Feb 2024. She owns shares worth $12,378,715 as insider, has earned $42,066,898 from insider trading and has received compensation worth at least $30,690,000 in Zoetis Inc..
What is the salary of Kristin C. Peck?
Ms. Kristin C. Peck salary is $2,790,000 per year as Chief Executive Officer & Director in Zoetis Inc..
How old is Kristin C. Peck?
Ms. Kristin C. Peck is 54 years old, born in 1971.
What stocks does Kristin C. Peck currently own?
As insider, Ms. Kristin C. Peck owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Zoetis Inc. (ZTS) | Chief Executive Officer & Director | 79,366 | $155.97 | $12,378,715 |
What does Zoetis Inc. do?
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Kristin C. Peck insider trading
Zoetis Inc.
Ms. Kristin C. Peck has made 35 insider trades between 2014-2024, according to the Form 4 filled with the SEC.
The largest trade she's ever made was exercising 32,000 units of ZTS stock on 21 Feb 2018. As of 20 Feb 2024 she still owns at least 79,366 units of ZTS stock.